NEW YORK (GenomeWeb News) – Seahorse Bioscience announced today that In Vitro Technologies is the new distributor of its Seahorse XF Analyzers and consumables in Australia and New Zealand.
Financial and other terms were not disclosed.
Seahorse Extracellular and Flux Analyzers provide the first and only kinetic method of measuring mitochondrial respiration and glycolysis, the two major energy-producing pathways, in living cells in a microplate, the North Billerica, Mass., firm said. The analyzers allow scientists to assess the impact of drugs, genetic modifications, and environment by monitoring oxygen consumption and the production of metabolic byproducts in cells.
"Our goal was to partner with a distributor who provides quality sales, service, and support to customers in the cell-based assay market," Steve Chomicz, vice president of sales and marketing for Seahorse, said in a statement. "The partnership with In Vitro will allow us to accelerate our sales as they have existing relationships with our ideal customer base."